Mitiglinide calcium structure
|
Common Name | Mitiglinide calcium | ||
|---|---|---|---|---|
| CAS Number | 207844-01-7 | Molecular Weight | 353.46 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H25NO3.1/2Ca.H2O | Melting Point | 179-185ºC | |
| MSDS | Chinese | Flash Point | N/A | |
Use of Mitiglinide calciumMitiglinide calcium hydrate is a drug for the treatment of type 2 diabetes; it is a highly selective KATP channel antagonist. IC50 value:Target: KATP channel |
| Name | Mitiglinide calcium |
|---|---|
| Synonym | More Synonyms |
| Description | Mitiglinide calcium hydrate is a drug for the treatment of type 2 diabetes; it is a highly selective KATP channel antagonist. IC50 value:Target: KATP channel |
|---|---|
| Related Catalog |
| Melting Point | 179-185ºC |
|---|---|
| Molecular Formula | C19H25NO3.1/2Ca.H2O |
| Molecular Weight | 353.46 |
| PSA | 111.68000 |
| LogP | 5.53020 |
| Storage condition | -20°C Freezer |
| HS Code | 2942000000 |
|---|
| HS Code | 2942000000 |
|---|
| 2H-Isoindole-2-butanoic acid, octahydro-γ-oxo-α-(phenylmethyl)-, calcium salt, (αS,3aR,7aS)-, hydrate (2:1:1) |
| MFCD08460119 |
| Mitiglinidecalcium |
| Calcium (2S)-2-benzyl-4-[(3aR,7aS)-octahydro-2H-isoindol-2-yl]-4-oxobutanoate hydrate (1:2:2) |
| 3006 MITIGLINIDE CALCIUM HYDRATE |
| KAD-1229 Calcium Hydrate |
| Mitiglinide calciuM salt dihydrate |